X.T.L. Biopharmaceuticals Overview

X.T.L. Biopharmaceuticals Selling, General & Admin

Selling, General & Admin expenses for XTLB.

Quarterly SG&A Expenses

$706000.00

↑ 263.92% YoY

As of Dec 31, 2024

Annual SG&A Expenses (TTM)

$2.05M

↑ 178.75% YoY

Trailing 12 months ending Dec 31, 2024

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin